echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > The national drug control platform is eyeing the unified bidding big data

    The national drug control platform is eyeing the unified bidding big data

    • Last Update: 2021-02-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Drug tender procurement of the national management wind and rain to come. The discussion draft of "Guidance on improving the centralized procurement of drugs in public hospitals", which has not been published, mentions that "patented drugs and exclusive production of drugs" are to be negotiated by the state for centralized procurement prices, and recently a research institution has revealed the preliminary contents of the drug negotiation mechanism of the National Health and Planning Commission: "Relying on the national drug supply integrated management information system platform to achieve information disclosure", "building professional negotiating groups, formulating negotiation implementation rules, strategies, negotiation platforms for the national drug supply integrated management information system platform or on-site negotiations". At present, Tianjin, Jiangsu, Zhejiang, Jiangxi, Shandong provinces (cities) of the centralized procurement platform and the national drug supply security integrated management information system interconnected.
    In addition, Mao Qun'an, a spokesman for the National Health planning commission, said at his first regular press conference in 2015 on January 12 that improving the drug supply guarantee system was one of the priorities of the National Health and Family Planning Work In 2015, drug price negotiations and centralized tender procurement of the entire drug, and that there was already a "package" of work, the document is still under approval.
    " National drug price formulation chess management is a big trend, and the establishment of the national drug supply security integrated management information system platform actually plays the role of information sharing, 5 provinces of Unicom is only the first step, the future of all provinces will achieve connectivity with this system. "In the interview, Kyusju Tong Group General Manager of Marketing Geng Hongwu was judged."big data collection
    " provinces tender procurement standards are various, enterprises are struggling to cope with, the root cause of which is the lack of a unified national drug procurement standards. Li Zhenjiang, chairman of Shenwei Pharmaceuticals, said.
    september last year, the Statistical Information Center held a technical seminar on the information exchange platform of the National Integrated Management Information System for Drug Supply Assurance. The relevant person in charge of the center pointed out that due to the lack of unified construction standards in the early stage, it is difficult for the provincial drug procurement information platform to achieve connectivity and resource sharing at this stage, which is very detrimental to the national level policy promotion, information supervision and the implementation of the basic drug system evaluation.
    The construction of the information exchange platform is aimed at using information technology to complete data exchange and data collection between the national and provincial drug bidding platforms, through data cleaning and storage, to study and analyze the implementation of the basic drug system and related policy measures and existing problems, in order to further improve the relevant drug policy to provide information support.
    " 5 provinces of the centralized procurement platform for drugs and the National Drug Supply Guarantee Integrated Management Information System, in fact, based on the previous bidding process procurement code and other information, the price of drugs, product regulations and other unified, easy to match the data. Mr Geng said.
    Xuhua, a senior marketing consultant at Beijing-based Sunrise Boyuan Management Consulting, believes that from a macro perspective, building a national platform is conducive to the relevant departments to develop large principles, overall programs and top-level design. It is good news that future drug tenders will be incorporated into the National Integrated Management Information System for Drug Supply Guarantee. "At present, drug prices across the country are in disarray, with ten prices in ten provinces and too much local difference. After the platform Unicom, drug prices will be more standardized, hospital drug use will be open and transparent, drug price reduction is a major trend, conducive to health insurance charges. "
    " personally believe that the main purpose of building this platform is to standardize bidding, for the future unified bidding accumulation data, according to the current trend, the entire bidding is certainly left and right linkage of the national chess. Jin Xuecai, deputy general manager of Spike Pharmaceuticals, said in an interview with this newspaper that the National Health and Planning Commission has always had the consideration of a unified national tender, so to do data mapping and preliminary preparation in advance.
    There are experts, the national drug management platform as an information platform, with the provincial drug centralized procurement center docking, will achieve the drug from the tender, distribution, use and settlement of the four links are real-time monitoring, the future of national classification procurement, national drug price negotiation mechanism and other negotiating prices will be published on this platform, the bidding center can be purchased accordingly.Price maintenance difficult
    " according to the plan, platform monitoring includes from bidding, distribution to drug settlement of all links, the current provincial tender reference is mainly the winning price, if monitored to the settlement link, in the current secondary bargaining gradually popularized, drug prices almost become an open secret. "Seber blue analysis, after the second bargain will soon become a national uniform price, which will bring great challenges to the price maintenance of pharmaceutical companies.
    " enterprises should have a global view, if the national linkage, from the price to unify and balance. Jin Xuecai said that if the national linkage, manufacturers in the price maintenance to pay special attention to. Because in the past the size of the provincial market and bidding model is not the same, the emergence of different prices around the situation is very normal. Once the national drug tender price linkage, information collection requires the provision of national data, for enterprises must sometimes consider some abandonment.
    this trend, companies must invest more in research and development innovation. "Previously only the region's centralized bidding, enterprises still have a certain living space. When the national centralized bidding, homogenization competition is more intense, then the product does not necessarily have an advantage. Once the national linkage, for enterprises with weak innovation, the impact will be greater, so we should use product differentiation and technological innovation to gain the advantages of market competition. "The aforementioned business person analysis.
    reporters understand that the above-mentioned national drug control platform in addition to drug prices for testing, there will be a publicity system. Lenovo previously proposed by the National Health and Planning Commission to establish a blacklist system for enterprises, Jin Xuecai believes that the openness of this platform, can promote the behavior of the entire industry more standardized. (Pharmaceutical Network)
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.